MV BioTherapeutics SA

Swiss Biotech Association

Member

A Swiss microbiota company with two technology platforms: ApyraVax for innovative mucosal vaccines against enteric infections; ApyraMed for live modified biotherapeutics with 2 lead products with indication in cancer immunotherapy of solid tumors and dysbiosis by antibiotics and unhealthy diet.

https://www.mv-bio.com/

Location

via Vincenzo Vela 6, 6500 Bellinzona, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2018
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Hengrui Europe Biosciences AG

Hengrui Europe Biosciences is a biotech start-up based in Zurich, Switzerland, established in 2021. We are a subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd. and are building a new research center with a differentiated technology platform to support innovative antibody discovery research.
8048 Zürich

Member

Praed Pharmaceuticals Ltd

Praed Pharmaceuticals is biopharmaceutical company founded by industry experts. Our mission is to deliver a next generation treatment for Crohn’s disease. We are developing a promising oral compound, cadazolid, for the treatment of Crohn’s disease.
4054 Basel

Member

Rivia SA

Rivia is a platform for Biotechs to oversee clinical trials in real-time by automatically combining data sources
Technoparkstrasse

Member